ascendis pharma glp-1 receptor agonist medications Understanding agonists and their impact on drug discovery GLP-1 Agonists: A Comprehensive Overview

For example, niches may be created by addressing specific unmet needs in certain patient types (e.g., patients who prefer not to inject, or who failed prior lines of GLP-1s), or by addressing specific access issues (e.g., developing a lower-cost option, securing broader payer coverage)

[DOI] [PubMed] [Google Scholar] 20.Lacasa D., Taleb S., Keophiphath M., Miranville A., Clement K

Diabetologia 50 , 471480 (2007)

An open-label, parallel group study investigating the effects of age and gender on the pharmacokinetics of the once-daily glucagon-like peptide-1 analogue liraglutide

Lancet Diabetes Endocrinol 2022;10:393-406.ArticlePubMed 134

These calculations become second nature quickly, but errors during the first few reconstitutions are common